Market Cap
$68.0B
CL
COLGATE PALMOLIVE CO
$84.37 ▼ -0.19%
Prev close $84.53Market cap$68.0B
ConsensusBuy
12-mo target$98.60 (+16.9%)
▲ Bullish
Analyst conviction 7/10
Insider Selling Cluster (2 insiders)32 New Institutional Positions18 Institutional ExitsCongressional Activity (1) Consumer & Retail
Snapshot
The big-picture read on CL right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (65%)
Inst. Holders
50 funds
Inst. Value
$42.3B
Inst. Activity
32 buys / 18 sells
Insider Activity
$0.00 buy / $31.2M sell
Insider Net $
-$31.2M
Social Sentiment
50° Neutral
SEC Reports
6
Congressional
5 trades
Price chart 30d -6.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 short_volume
Short Volume: CL — 62.7% short (0.8M / 1.3M)
Short: 817,735 | Exempt: 2,724 | TRF Vol: 1,304,861 | Short Ratio: 62.7% | Off-exchange volume (dark
Sep 16, 2026 Insider
Tsourapas Panagiotis was granted 31,814 shares
COO, CD, EMEA, APac, Skin
Sep 16, 2026 Insider
Hazlin John was granted 3,908 shares
Chief Growth Officer
Sep 16, 2026 Insider
Wallace Noel R. was granted 205,197 shares
Chairman, President & CEO
Aug 19, 2026 Congress
Aug 8, 2026 SEC Kevin Hern sell
$1,001 - $15,000 — House
Colgate-Palmolive CEO Noel Wallace sold $29.7M worth of stock on Aug 4-5, 2026, following the Q2 earnings beat reported
CLUSTER — Impact 3/10
Colgate-Palmolive reported Q2 2026 results with net sales up 4.9% to $5.361B and GAAP EPS declining 5% to $0.86, while B
8-K — Impact 5/10
This is a routine procedural ruling denying a pro se plaintiff's motion for relief under Rule 60 from dismissals that we
COURT-RULING — Impact 1/10
Analyst ratings buy % +8.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
65% rate it Buy or better · 31 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 21, 2026 | Piper Sandler | MAINTAIN | Overweight | 54% |
| Sep 8, 2026 | RBC Capital | REITERATE | Outperform | 55% |
| Aug 3, 2026 | UBS | MAINTAIN | Buy | 55% |
| Aug 3, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| Aug 3, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Aug 3, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Aug 3, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Jul 21, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
| Jul 16, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jul 16, 2026 | UBS | MAINTAIN | Buy | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 15 | 10 | 0 | 1 | 65% | |
| Aug 1, 2026 | 5 | 15 | 10 | 0 | 1 | 65% | |
| Jul 1, 2026 | 5 | 15 | 10 | 0 | 1 | 65% | |
| Jun 1, 2026 | 5 | 15 | 9 | 0 | 1 | 67% | |
| May 1, 2026 | 5 | 15 | 9 | 0 | 1 | 67% | |
| Apr 1, 2026 | 5 | 14 | 10 | 0 | 1 | 63% | |
| Mar 1, 2026 | 5 | 14 | 10 | 0 | 1 | 63% | |
| Feb 1, 2026 | 5 | 14 | 10 | 0 | 1 | 63% |
Price targets
Where 20 covering analysts think CL trades over the next 12 months.
$98.60 +16.9% upside Buy
Current$84.37 Low$87.00 Median$100.00 High$110.00 20 analysts
$87.00$110.00
Analyst rating Buy· 2.0/5 as of Oct 2, 2026
Social media sentiment mood -28.6%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 5 neutral · avg impact 3.5/10.
NEUTRALCLUSTER3/10
Colgate-Palmolive CEO Noel Wallace sold $29.7M worth of stock on Aug 4-5, 2026, following the Q2 ear
Aug 8, 2026
NEUTRAL8-K5/10
Colgate-Palmolive reported Q2 2026 results with net sales up 4.9% to $5.361B and GAAP EPS declining
Jul 31, 2026
NEUTRALCOURT-RULING1/10
This is a routine procedural ruling denying a pro se plaintiff's motion for relief under Rule 60 fro
Jul 3, 2026
BEARISHCOURT-RULING6/10
A federal district court denied Colgate-Palmolive's motion to dismiss two putative class actions (th
May 16, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
short_volume
Short Volume: CL — 62.7% short (0.8M / 1.3M)
Short: 817,735 | Exempt: 2,724 | TRF Vol: 1,304,861 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: CL — 58.2% short (0.6M / 1.1M)
Short: 624,325 | Exempt: 2,516 | TRF Vol: 1,072,833 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: CL — 68.1% short (0.9M / 1.3M)
Short: 864,059 | Exempt: 2,770 | TRF Vol: 1,269,510 | Short Ratio: 68.1% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: CL — 66.1% short (1.1M / 1.7M)
Short: 1,099,705 | Exempt: 1,738 | TRF Vol: 1,662,541 | Short Ratio: 66.1% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: CL — 64.6% short (1.1M / 1.7M)
Short: 1,095,741 | Exempt: 6,099 | TRF Vol: 1,695,743 | Short Ratio: 64.6% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.93 | $0.89–$0.96 | 2.2% | +0.0% | 8↑ 6↓ | $5.3B | 17 |
| Next Q | $0.97 | $0.93–$0.99 | 1.7% | -0.2% | 10↑ 5↓ | $5.4B | 17 |
| Current FY | $3.87 | $3.83–$4.02 | 5.0% | -0.1% | 18↑ 1↓ | $21.4B | 20 |
| Next FY | $4.10 | $4.00–$4.19 | 5.9% | -0.2% | 16↑ 2↓ | $22.1B | 20 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.930 | — |
| 7d ago | $0.930 | — |
| 30d ago | $0.930 | — |
| 60d ago | $0.922 | +0.007 |
| 90d ago | $0.922 | +0.007 |
Institutional ownership
Which big funds own CL (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $42.3B total value (461,345,940 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 32 institutions added/increased vs 18 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 69,915,472 | $6.4B | 15.1% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 52,246,333 | $4.8B | 11.3% | — |
| STATE STREET CORP | 47,020,966 | $4.3B | 10.2% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 24,021,137 | $2.2B | 5.2% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 23,144,319 | $2.1B | 5.1% | — |
| MORGAN STANLEY | 22,072,925 | $2.0B | 4.8% | — |
| Bank of New York Mellon Corp | 13,532,417 | $1.2B | 2.9% | — |
| DEUTSCHE BANK AG\ | 11,751,973 | $1.1B | 2.5% | — |
| NORGES BANK | 9,686,029 | $888.0M | 2.1% | NEW |
| FMR LLC | 8,983,071 | $823.6M | 1.9% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 9,686,029 | — | $888.0M |
| CITADEL ADVISORS LLC | ADD | 3,183,995 | 4,583,987 | +44.0% | $420.3M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 5,584,998 | 3,963,454 | -29.0% | $363.4M |
| AMERICAN CENTURY COMPANIES INC | ADD | 2,315,341 | 3,258,357 | +40.7% | $298.7M |
| Quantinno Capital Management LP | ADD | 1,449,131 | 2,202,031 | +52.0% | $201.9M |
| Vinva Investment Management Ltd | ADD | 1,176,008 | 2,088,720 | +77.6% | $193.8M |
| CANADA PENSION PLAN INVESTMENT BOARD | ADD | 1,141,934 | 1,986,101 | +73.9% | $182.1M |
| SCHRODER INVESTMENT MANAGEMENT GROUP | ADD | 1,407,406 | 1,975,868 | +40.4% | $181.1M |
| MACKENZIE FINANCIAL CORP | TRIM | 3,535,021 | 1,763,809 | -50.1% | $161.7M |
| Assenagon Asset Management S.A. | DOUBLED | 711,179 | 1,701,244 | +139.2% | $156.0M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
12 insiders, 50 transactions. Net -$31.2M — $0.00 bought, $31.2M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | AWARD | 31,814 | — | — |
| Sep 16, 2026 | Hazlin John | Chief Growth Officer | AWARD | 3,908 | — | — |
| Sep 16, 2026 | Wallace Noel R. | Chairman, President & CEO | AWARD | 205,197 | — | — |
| Sep 16, 2026 | SUTULA STANLEY J III | Chief Financial Officer | AWARD | 8,045 | — | — |
| Sep 16, 2026 | Wallace Noel R. | Chairman, President & CEO | AWARD | 29,649 | — | — |
| Sep 16, 2026 | SUTULA STANLEY J III | Chief Financial Officer | AWARD | 55,674 | — | — |
| Sep 16, 2026 | Malcolm Gregory | EVP and Controller | AWARD | 1,081 | — | — |
| Sep 16, 2026 | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | AWARD | 4,597 | — | — |
| Sep 16, 2026 | Fishbone Betsy | CLO and Secretary | AWARD | 2,207 | — | — |
| Sep 16, 2026 | Fishbone Betsy | CLO and Secretary | AWARD | 15,271 | — | — |
Congressional trades
CL trades disclosed by members of Congress, with disclosure delay.
4 members · 3 buys / 2 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Kevin Hern | R | HOUSE | SELL | $1,001 - $15,000 | Colgate-Palmolive Co | Sep 2, 2026(15d) |
| Jun 2, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Colgate-Palmolive Co | Jul 8, 2026(37d) |
| Sep 23, 2025 | Julie Johnson | D | HOUSE | SELL | $1,001 - $15,000 | Colgate-Palmolive Co | Aug 6, 2026(318d) |
| Sep 23, 2025 | Julie Johnson | D | HOUSE | BUY | $1,001 - $15,000 | Colgate-Palmolive Co | Aug 6, 2026(318d) |
| Apr 8, 2025 | John Boozman | R | SENATE | BUY | $1,001 - $15,000 | Colgate-Palmolive Co | Aug 20, 2026(500d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CL.
Shares short
18,399,416
Settlement Sep 15, 2026
Change vs prior
+7.2%
Semi-monthly cycle
Days to cover
4.0
At avg daily volume
Of shares outstanding
≈2.3%
Estimate — not % of float
All CL filing & press-release reports (6)
- CLUSTER reportAug 8, 2026
- 8-K reportJul 31, 2026
- COURT-RULING reportJul 3, 2026
- COURT-RULING reportMay 16, 2026
- 8-K reportApr 9, 2026
- DEFA14A reportMar 25, 2026